EQUITY CROWDFUNDING

1. EQUITY CROWDFUNDING FOR ADVANCED ELECTRONIC BIOSYSTEM

2. MISSION • WHO WE ARE: • AEB is an Italian Startup born from the Thermo Medical Sensor Project • The company is made up of a group of people with different skills, in the world of electronics and telecommunications systems • AEBiosystem actively works on research projects in the medical field, in everything related to the integration of electronic devices with the human body • Our idea wants to satisfy the need for a changing market. Wearable medical devices represent a frontier that is increasingly gaining acceptance from the market. AEBiosystem proposes a line of products that want to meet this need, through a range of thin sensors and the size of a normal patch. Our device stick to the skin like a patch and allow the measurement of temperature without the need for a battery. AEBiosystem ThermoMedical

3. Problem The most used device to get temperature is the Digital Thermometer • This technology no longer reflects current standards • Errors due to positioning can give false measures 01 03 02 • The measurement is not comfortable and is not immediate 04 • A continuous measurement is very difficult AEBiosystem ThermoMedical

4. Solution • What we have realized: • We have made a TEMPERATURE sensor that attaches to the skin simply as a patch • Don’t need BATTERY, and can be read simply by NFC Phone using an APP • This is the MOST SMALLER temperature sensor in the world. The sensor is just 0,8mm thin AEBiosystem ThermoMedical

5. Solution AEBiosystem ThermoMedical

6. Market In 2018 the worldwide market revenue for thermometers was 1270 MLN $ AEBiosystem

7. Market In 2018 the worldwide market revenue for thermometers was 1270 MLN $ AEBiosystem

8. Sensor Patch technology The patch is stuck in a part of the armpit. The temperature reading is performed by moving the phone closer to the patch. When the reading is performed, the phone emits a sound to confirm the reading. AEBiosystem ThermoMedical

9. We will develop 3 patch product line, that will be available in Pharmacy and Authorized Distributor STRATEGY INNOVATION POINT PARTNERSHIP FUNDING • XXX • XX • XX • XX • XXX • XX • XX • XX • XXX • XX • XX • XX Hospital and Professioninal Area Consumer Market AEBiosystem ThermoMedical

10. Competitorsanalysis • At present the market does not present many competitors on the wearable thermometer market • The few brands that distribute wearable thermometers offer very bulky solutions, that do not integrate with human anatomy • The sensor developed by AEBiosystem, is flexible and adapts to the body AEBiosystem ThermoMedical

11. RevenueModel How This Work ? Goal 3 1 2 4 Step 4 Step 3 Step 2 Step 1 To date, AEB has received interest from a large multinational company to acquire around 100,000 pieces of the product per year Industrialization of the Prototype The product will have to be industrialized, in order to reach the market on schedule CertificationThe product must be certified in order to be sold as an electronic device for medical use Marketing campaign preparationAt this stage, a sales strategy will be developed Product launch on the marketThe product will be launched on the market through the pharmaceutical distribution market AEBiosystem ThermoMedical

12. Management Team • Paolo Marini is the CEO and founder of AEBiosystem. He is an Electronic Engineer and his training comes from the world of aerospace research • Mauro Rosati is a Telecommunications Engineer with extensive experience in wireless communication systems • Giorgio Di Cioccio is a Informatic Engineer with a great deal of experience on mobile devices • MariaritaRaponi is an accountant and has followed AEBiosystem since its foundation Paolo Marini CEO Giorgio Di Cioccio Mariarita Raponi Mauro Rosati R&D Engineer Administration R&D Engineer AEBiosystem ThermoMedical

13. MILESTONES 2019 The first year will be necessary to complete the project and develop a market strategy 2022 AEBiosystem will start the development of a new product line 2020The project will be terminated and will be ready for market access 2023Market launch of new product line BLE 2021 Product LaunchAEBiosystem will produce profit AEBiosystem ThermoMedical

14. Investorproposition • AEBiosystem, will use the financial resources in the following way: • Staff expansion • Investment in Patent and Certification • Research and Developement • Production Line R&DResearch, Development and Consolidation of the Thermo Medical project Investment required: €950K (30% Equity) %15 Patent & CertificationAeBiosystem holds a worldwide patent application, which will soon be extended to countries of strategic interest Valutazione Pre-money:€5.0M %15 RecruitmentIn order to accelerate the development process, it will be necessary to recruit key figures in the field of sales %25 %45 ProductionAEBiosystem will set up a new production line in order to obtain high production volumes AEBiosystem ThermoMedical

15. Evaluation Market Evaluation Successfull Lifeseeder ScientificEvaluation Successfull Cluster C.H.I.C.O. DLA Piper LegalEvaluation Successfull Step 4 Logo Società Logo società target